Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalinski

Showing results (421-430 of 424) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 424 results.
Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8<sup>+</sup> T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.
Nature Communications|October 8, 2025
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancerGesa Mittmann, Sara Laiouar-Pedari, Hendrik A Mehrtens, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Journal of Translational Medicine|December 16, 2011
Defining the critical hurdles in cancer immunotherapyBernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.
Pageof 43

Showing results (421-430 of 424) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 424 results.
Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8<sup>+</sup> T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.
Nature Communications|October 8, 2025
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancerGesa Mittmann, Sara Laiouar-Pedari, Hendrik A Mehrtens, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Journal of Translational Medicine|December 16, 2011
Defining the critical hurdles in cancer immunotherapyBernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.
Pageof 43